PriceTargets.com logo

Cibus - CBUS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $22.83
  • Forecasted Upside: 475.15%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$3.97 As of 11/20/2024 01:00 AM ET
▼ -0.37 (-8.53%)

This chart shows the closing price for CBUS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cibus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CBUS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CBUS

Analyst Price Target is $22.83
▲ +475.15% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Cibus in the last 3 months. The average price target is $22.83, with a high forecast of $25.00 and a low forecast of $20.00. The average price target represents a 475.15% upside from the last price of $3.97.

This chart shows the closing price for CBUS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Cibus.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/11/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/22/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
9/24/2024Alliance Global PartnersLower TargetBuy ➝ Buy$25.00 ➝ $23.50
9/19/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$21.00 ➝ $20.00
8/12/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$22.00 ➝ $21.00
7/29/2024Alliance Global PartnersInitiated CoverageBuy$25.00
7/19/2024Canaccord Genuity GroupUpgradeStrong-Buy
7/19/2024Canaccord Genuity GroupReiterated RatingBuy$22.00
5/10/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
3/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
10/9/2023HC WainwrightInitiated CoverageNeutral ➝ Buy$25.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.33 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024
  • 1 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
5/24/2024
  • 2 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/23/2024
  • 5 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/23/2024
  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/22/2024
  • 0 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 4 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024

Current Sentiment

  • 4 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cibus logo
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Read More

Today's Range

Now: $3.97
Low: $3.94
High: $4.40

50 Day Range

MA: $4.01
Low: $2.94
High: $5.75

52 Week Range

Now: $3.97
Low: $2.86
High: $23.18

Volume

143,603 shs

Average Volume

136,801 shs

Market Capitalization

$105.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79

Frequently Asked Questions

What sell-side analysts currently cover shares of Cibus?

The following Wall Street research analysts have issued reports on Cibus in the last twelve months: Alliance Global Partners, Canaccord Genuity Group Inc., and HC Wainwright.
View the latest analyst ratings for CBUS.

What is the current price target for Cibus?

0 Wall Street analysts have set twelve-month price targets for Cibus in the last year. Their average twelve-month price target is $22.83, suggesting a possible upside of 475.1%. HC Wainwright has the highest price target set, predicting CBUS will reach $25.00 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of $20.00 for Cibus in the next year.
View the latest price targets for CBUS.

What is the current consensus analyst rating for Cibus?

Cibus currently has 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CBUS will outperform the market and that investors should add to their positions of Cibus.
View the latest ratings for CBUS.

What other companies compete with Cibus?

Other companies that are similar to Cibus include Marrone Bio Innovations, LifeVantage, American Vanguard, Natural Alternatives International and Mannatech. Learn More about companies similar to Cibus.

How do I contact Cibus' investor relations team?

Cibus' physical mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company's listed phone number is (858) 450-0008 and its investor relations email address is [email protected]. The official website for Cibus is www.calyxt.com. Learn More about contacing Cibus investor relations.